| Elizabeth Auld, | |
|
202 N Division St, Auburn, WA 98001-4939 | |
| (206) 790-5900 | |
| Not Available |
| Full Name | Elizabeth Auld |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 7 Years |
| Location | 202 N Division St, Auburn, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346774353 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 61165456 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Multicare Auburn Medical Center | Auburn, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cascade Emergency Physicians Inc | 8527955871 | 24 |
News Archive
United Water and the National Community Pharmacists Association (NCPA) announced a partnership today to encourage people throughout the United States to properly dispose of their unused or expired medications in an environmentally-friendly manner. A major part of the campaign will center around the NCPA's website dedicated to the program - www.DisposeMyMeds.org - that directs people to their local independent pharmacy where they can drop off their unused medications.
MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that the U.S. Patent and Trademark Office (USPTO) issued a composition of matter patent covering its clinical candidate, MRX-I. MRX-I is a novel antibacterial oxazolidinone that targets infections due to multi-drug resistant Gram-positive pathogens.
The French National Institute of Health and Medical Research (Inserm) is currently the leading biomedical research organisation in Europe, and plays a key role in developing European research. To mark its 50th anniversary, Inserm wanted to assess the perceptions of Europeans regarding biomedical research.
Millions of Americans suffering from psoriasis and psoriatic arthritis got a year-end boost from the federal government when it approved $1.5 million for the first-ever psoriasis patient registry at the Centers for Disease Control (CDC).
NanoViricides, Inc. announced today that it has been invited to present its anti-influenza drug development studies at the TechConnect World 2011 Conferences and Expo.
› Verified 5 days ago
| Entity Name | Cascade Emergency Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225060734 PECOS PAC ID: 8527955871 Enrollment ID: O20040302000157 |
News Archive
United Water and the National Community Pharmacists Association (NCPA) announced a partnership today to encourage people throughout the United States to properly dispose of their unused or expired medications in an environmentally-friendly manner. A major part of the campaign will center around the NCPA's website dedicated to the program - www.DisposeMyMeds.org - that directs people to their local independent pharmacy where they can drop off their unused medications.
MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that the U.S. Patent and Trademark Office (USPTO) issued a composition of matter patent covering its clinical candidate, MRX-I. MRX-I is a novel antibacterial oxazolidinone that targets infections due to multi-drug resistant Gram-positive pathogens.
The French National Institute of Health and Medical Research (Inserm) is currently the leading biomedical research organisation in Europe, and plays a key role in developing European research. To mark its 50th anniversary, Inserm wanted to assess the perceptions of Europeans regarding biomedical research.
Millions of Americans suffering from psoriasis and psoriatic arthritis got a year-end boost from the federal government when it approved $1.5 million for the first-ever psoriasis patient registry at the Centers for Disease Control (CDC).
NanoViricides, Inc. announced today that it has been invited to present its anti-influenza drug development studies at the TechConnect World 2011 Conferences and Expo.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Auld, 3852 E Olive St, Seattle, WA 98122-3562 Ph: (206) 790-5900 | Elizabeth Auld, 202 N Division St, Auburn, WA 98001-4939 Ph: (206) 790-5900 |
News Archive
United Water and the National Community Pharmacists Association (NCPA) announced a partnership today to encourage people throughout the United States to properly dispose of their unused or expired medications in an environmentally-friendly manner. A major part of the campaign will center around the NCPA's website dedicated to the program - www.DisposeMyMeds.org - that directs people to their local independent pharmacy where they can drop off their unused medications.
MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that the U.S. Patent and Trademark Office (USPTO) issued a composition of matter patent covering its clinical candidate, MRX-I. MRX-I is a novel antibacterial oxazolidinone that targets infections due to multi-drug resistant Gram-positive pathogens.
The French National Institute of Health and Medical Research (Inserm) is currently the leading biomedical research organisation in Europe, and plays a key role in developing European research. To mark its 50th anniversary, Inserm wanted to assess the perceptions of Europeans regarding biomedical research.
Millions of Americans suffering from psoriasis and psoriatic arthritis got a year-end boost from the federal government when it approved $1.5 million for the first-ever psoriasis patient registry at the Centers for Disease Control (CDC).
NanoViricides, Inc. announced today that it has been invited to present its anti-influenza drug development studies at the TechConnect World 2011 Conferences and Expo.
› Verified 5 days ago
Sidney Beers, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 202 N Division St, Auburn, WA 98001 Phone: 253-833-7711 | |
Richard Mcmonigal, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 202 N Division St, Auburn, WA 98001 Phone: 253-833-7711 | |
Dr. Lee Wood, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 202 N Division St, Auburn, WA 98001 Phone: 713-873-2630 | |
Stephen H. Anderson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 202 N Division St, Auburn, WA 98001 Phone: 253-833-7711 | |
Robert Richling, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 202 N Division St, Plaza One, Auburn, WA 98001 Phone: 253-833-7711 | |
Robert Bessler, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 202 N Division St, Auburn, WA 98001 Phone: 253-833-7711 |